Back to UBS Group AG UBS Group AG

CLRBCLRB
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in CELLECTAR BIOSCIENCES INC

UBS Group AG holds 3,093 shares of CLRB (CELLECTAR BIOSCIENCES INC), worth $8,599 as of 2026-Q2. The position was decreased (-67.9% shares).

Current Value

$8,599

Current Shares

3,093

Total Value Change

-$17,139

Total Shares Change

-527

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3,093
-67.9%
$8,5990.0%$2.78
0
2026-Q1
Increased
9,647
+271.3%
$24,5040.0%$2.68
21
2025-Q4
Increased
2,598
+186.1%
$7,6640.0%$2.74
18
2025-Q3
Decreased
908
-74.9%
$5,0840.0%$5.41
0
2025-Q2
New
3,620
-
$25,7380.0%$7.90
29

Other major holders of CLRB: VANGUARD CAPITAL MANAGEMENT LLC, BALYASNY ASSET MANAGEMENT L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used